Registry of cancer patients with thromboembolism

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on patients diagnosed with cancer who experience venous or arterial thromboembolic events either prior to or following their cancer diagnosis. It is a multicentric study that will document these occurrences to better understand the relationship between cancer and thromboembolism. Patients over 18 years old with a confirmed malignant tumor and a documented thromboembolic episode will be included. The study will utilize imaging techniques for confirmation of thromboembolic events.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Over 18 years of age with a histologically confirmed diagnosis of malignant tumor.
* Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc.
* Signing of informed consent.

Exclusion Criteria:

* Clinical diagnosis of thromboembolic event without radiological confirmation.
* Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event.
* Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.

Where it's running

• Hospital Virgen de los Lirios
  Alcoy, Alicante, Spain Recruiting
• Hospital Universitario de Torrevieja
  Elche, Alicante, Spain Recruiting
• Hospital Son Espases
  Palma, Balearic Islands, Spain Recruiting
• Institut Català D'Oncologia (ICO) L'Hospitalet
  L'Hospitalet de Llobregat, Barcelona, Spain Recruiting
• Hospital Universitari Parc Taulí
  Sabadell, Barcelona, Spain Recruiting
• Hospital De Sant Joan Despi Moissès Broggi
  Sant Joan Despí, Barcelona, Spain Recruiting

Study contacts

• Study coordinator: Andres Muñoz, M.D.
• Email: investigacion@mfar.net
• Phone: +34 93 434 44 12

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tailored lower‑intensity blood thinner plan after left atrial appendage closure to prevent stroke

  This project tests whether people with non‑valvular atrial fibrillation who get a left atrial appendage closure can stop blood thinners after taking low‑dose apixaban (2.5 mg twice daily) for 3 months, compared with people who stay on standard‑dose DOACs.

  Recruiting National Medical Research Center for Therapy and Preventive Medicine · Moscow · NCT07575867

• Cardiovascular risk in people with Crohn's disease and ulcerative colitis

  This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Milan · NCT07095634

• Assessing Peripheral Arterial Disease in Patients with Deep Vein Thrombosis

  This study looks at how common Peripheral Arterial Disease is in people with unprovoked Deep Vein Thrombosis and compares it to those with other types of DVT to see how their heart health is related.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT06806540

• Using tranexamic acid to reduce bleeding in major colorectal surgery

  This study is testing if giving tranexamic acid before major colorectal surgery can help reduce bleeding during and after the operation for patients.

  Recruiting Phase 2 The Cleveland Clinic · Cleveland, Ohio · NCT06657924

• Comparing blood thinners for patients on ECMO support

  This study is testing whether two different blood thinners, argatroban and enoxaparin, can work as well as the usual treatment, heparin, for patients on ECMO support.

  Recruiting Phase 4 Medical University of Vienna · Vienna, State of Vienna · NCT06442267

• Detecting blood clots in patients with thromboembolism

  This study is testing a new device to see if it can better detect blood clots in patients with thromboembolic disease.

  Recruiting University of Arkansas · Little Rock, Arkansas · NCT05301348

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.